Tang Capital Management’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.05M Sell
666,022
-1,465,285
-69% -$6.22M 0.1% 45
2025
Q4
$7.69M Hold
2,131,307
0.38% 48
2025
Q3
$8.04M Sell
2,131,307
-618,693
-22% -$2.39M 0.31% 72
2025
Q2
$10.6M Hold
2,750,000
0.54% 48
2025
Q1
$13.8M Hold
2,750,000
0.76% 36
2024
Q4
$19.8M Hold
2,750,000
1.31% 19
2024
Q3
$16.9M Hold
2,750,000
1.21% 24
2024
Q2
$18.3M Hold
2,750,000
1.86% 13
2024
Q1
$28M Hold
2,750,000
2.91% 6
2023
Q4
$30.9M Hold
2,750,000
2.86% 9
2023
Q3
$7.15M Hold
2,750,000
1.01% 34
2023
Q2
$9.71M Hold
2,750,000
1.43% 22
2023
Q1
$11.6M Buy
2,750,000
+49,550
+2% +$589K 1.73% 18
2022
Q4
$44.4M Buy
2,700,450
+100,000
+4% +$1.12M 6.45% 2
2022
Q3
$33.2M Sell
2,600,450
-1,000,000
-28% -$14.8M 4.07% 5
2022
Q2
$42.1M Buy
3,600,450
+1,026,706
+40% +$6.33M 6.39% 3
2022
Q1
$15.7M Buy
2,573,744
+973,744
+61% +$7.17M 3.14% 8
2021
Q4
$14.7M Hold
1,600,000
2.95% 8
2021
Q3
$18.1M Buy
1,600,000
+816,593
+104% +$9.93M 3.76% 9
2021
Q2
$7.72M Buy
+783,407
New +$10.7M 1.54% 9

Other funds holding ALT

Tang Capital Management's ALT Position: Q1 2026 in Review

Tang Capital Management reduced its Altimmune (ALT) stake by 69% in Q1 2026, selling an estimated $6.22M and leaving 666,022 shares worth $2.05M. The position accounts for 0.1% of the portfolio, ranked #45.

Tang Capital Management first reported a position in ALT in Q2 2021 and has held it in 20 quarters since. The position peaked at $44.4M in Q4 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Tang Capital Management held 666,022 shares of Altimmune worth $2.05M as of Q1 2026.
  • Tang Capital Management sold 1,465,285 Altimmune shares in Q1 2026, an estimated $6.22M.
  • Altimmune made up 0.1% of Tang Capital Management's portfolio in Q1 2026, its #45 holding.
  • Tang Capital Management first reported a position in Altimmune in Q2 2021 and has held it in 20 quarters since.
  • Tang Capital Management's Altimmune position peaked at $44.4M in Q4 2022.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Tang Capital Management's 13F filing for Q1 2026, filed 15 May 2026.